Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

2018

The original version of this article unfortunately contained a mistake. The co-authors’ names were incorrect.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

0

Citations